Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Haemonetics Corporation (HAE) has a market cap of $2.81B with year-over-year revenue growth of +4.0%. Net margin stands at 12.3%. The stock trades at a P/E ratio of 16.8.
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, HAE posted revenue growth of +4.0% and trades at a P/E of 16.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.